Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride

Shagera, Qaid Ahmed; Gheysens, Olivier; Jonard, Emilie; Seront, Emmanuel; Lhommel, Renaud; Lecouvet, Frédéric; Tombal, Bertrand; Jamar, François

doi:10.1007/s00259-025-07589-1

Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride

Shagera, Qaid Ahmed

;

Gheysens, Olivier

;

Jonard, Emilie

;

Seront, Emmanuel

;

Jamar, François

;et.al.

(2025) European Journal of Nuclear Medicine and Molecular Imaging — Vol. 53, n° 3, p. 1782-1788 (2025)

Files

Shagera_40996523.pdf

Open Access
Adobe PDF
1.11 MB

Download

Details

Authors

Shagera, Qaid AhmedUCLouvain
Author
Gheysens, OlivierUCLouvain
Author
Jonard, EmilieUCLouvain
Author
Seront, EmmanuelUCLouvain
Author
Lhommel, RenaudUCLouvain
Author
Lecouvet, FrédéricUCLouvain
Author
Tombal, BertrandUCLouvain
Author
Jamar, FrançoisUCLouvain
Author

Affiliations

Citations

APA
Chicago
FWB

Shagera, Q. A., Gheysens, O., Jonard, E., Seront, E., Lhommel, R., Lecouvet, F., Tombal, B., & Jamar, F. (2025). Bone marrow scintigraphy as a prognostic marker of overall survival in mCRPC patients treated with Radium-223 dichloride. European Journal of Nuclear Medicine and Molecular Imaging, 53(3), 1782-1788. https://doi.org/10.1007/s00259-025-07589-1 (Original work published 2025)